Global burden of disease study at the world health organization:
                    research methods for the most comprehensive global study of disease and
                    underlying health policies

Smıth, Lee; Shin, Jae Il; Hwang, Soo Young; Tizaoui, Kalthoum; Dragioti, Elena; Jacob, Louis; Kostev, Karel; Lee, Seung Won; Koyanagi, Ai

doi:10.54724/lc.2022.e8

Cited by 22 publications

(16 citation statements)

References 18 publications

(36 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our analysis was performed as part of the GBD Collaborator Network and complied with the Guidelines for Accurate and Transparent Health Estimates Reporting (Supplementary Method). A comprehensive methodology for the estimation models has been published elsewhere 15,16 …”

Section: Methodsmentioning

confidence: 99%

“…Surveys carried out as part of the International Study of Asthma and Allergies in Childhood (ISAAC) collaboration are the most important source of prevalence data in children. 15,16,19 AD, consistent with ICD-10 code L20 and ICD-9 code L691, was defined as relapsing dermatitis, either localized or widespread, associated with pruritus, elevated serum immunoglobulin E, and immune dysregulation. 1,12 However, the potential variation in the accuracy of physician diagnosis and symptom data across regions and differences in healthcare access, diagnostic criteria, and medical knowledge may result in under-or over-diagnosis of diseases.…”

Section: Case Definitionmentioning

confidence: 99%

“…Lastly, we combined various risk factors through other factors. A high BMI was defined as a BMI over 25.0 kg/m 2 for adults, which is considered overweight or obese, and as being overweight or obese for children (ages [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] on International Obesity Task Force standards.…”

Section: Risk Factorsmentioning

confidence: 99%

See 2 more Smart Citations

Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019

Smıth

Hwang

Kwon

et al. 2023

Allergy

Self Cite

124

View full text Add to dashboard Cite

Background: Asthma and atopic dermatitis (AD) are chronic allergic conditions, along with allergic rhinitis and food allergy and cause high morbidity and mortality both in children and adults. This study aims to evaluate the global, regional, national, and temporal trends of the burden of asthma and AD from 1990 to 2019 and analyze their associations with geographic, demographic, social, and clinical factors.Methods: Using data from the Global Burden of Diseases (GBD), Injuries, and Risk Factors Study 2019, we assessed the age-standardized prevalence, incidence, mortality, and disability-adjusted life years (DALYs) of both asthma and AD from 1990 to 2019, stratified by geographic region, age, sex, and socio-demographic index (SDI).DALYs were calculated as the sum of years lived with disability and years of life lost to premature mortality. Additionally, the disease burden of asthma attributable to high body mass index, occupational asthmagens, and smoking was described.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Case Definitionmentioning

confidence: 99%

See 1 more Smart Citation

Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019

Smıth

Hwang

Kwon

et al. 2023

Allergy

Self Cite

124

View full text Add to dashboard Cite

show abstract

“…This study used data extracted from the GBD 2019 database. The GBD 2019 provides data on 369 diseases and injuries and 87 risk factors in 204 countries and territories in 21 GBD‐defined regions from 1990 to 2019 26,27,35 . More detailed descriptions of the methodology have been reported elsewhere, 26,28,29 and overall changes in methodology from GBD 2017 are described in Table S1 (available via Mendeley at https://data.mendeley.com/datasets/9wnm4s37j5/1).…”

Section: Methodsmentioning

confidence: 99%

Global, regional and national burden of alopecia areata and its associated diseases, 1990–2019: A systematic analysis of the Global Burden of Disease Study 2019

Jang

Park

Kim

et al. 2023

Eur J Clin Investigation

View full text Add to dashboard Cite

Background No study to date has concomitantly reported the global burden of alopecia areata (AA) and its associated diseases. Methods The crude and age‐standardized rates of prevalence (ASPR), incidence (ASIR) and years lived with disability (YLDs) of AA were extracted from the global burden of disease, injuries and risk factors study (GBD) database between 1990 and 2019 for 204 countries and territories. We stratified the analysis by global region, nation, sex, age and sociodemographic index (SDI) to dissect the epidemiology of AA and its associated diseases. Results Alopecia areata was responsible for 0.024% of the total DALYs. Age‐standardized DALYs rate of AA was 7.51 [4.73–11.14] per 100,000. Overall ASPR, ASIR and age‐standardized YLDs rates were stable from 1990 to 2019 globally. All three rates were about two times higher in females compared to males and had a bimodal distribution with peaks at age 30–34 years and 60–64 years. AA burden was positively correlated with SDI (r = .375, p < .001) and was most prevalent in high‐income countries, especially North America. Countries with a high AA incidence were more likely to have high incidences of autoimmune diseases and low incidences of ischaemic heart disease and ischaemic stroke. Conclusions The burden of AA was prominent in females, young adults, high sociodemographic countries and North Americans. The study corroborates sex‐ and region‐specific implications and public health measures for AA and its associated burdens. These epidemiological data on AA burden can guide future research efforts, prevention strategies and allocation of resources.

show abstract

“…It is an ongoing study updated annually including the incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) of 369 diseases and injuries, for two sexes in 204 countries and territories from 1990 to 2019 [ 27 ]. The GBD provides information for researchers and clinicians in discovering the latest knowledge and the current status of health for populations and countries worldwide [ 28 ]. In this study, HIV burden from 2000 to 2019 in post-neonatal population from East Asian was selected to analyze the time trends of incidence and mortality during 2010–2019 as well as the predicted trends of incidence and mortality in these patients.…”

Section: Methodsmentioning

confidence: 99%

A hybrid of long short-term memory neural network and autoregressive integrated moving average model in forecasting HIV incidence and morality of post-neonatal population in East Asia: global burden of diseases 2000–2019

Chen

Wang

2022

BMC Public Health

View full text Add to dashboard Cite

Background To forecast the human immunodeficiency virus (HIV) incidence and mortality of post-neonatal population in East Asia including North Korea, South Korea, Mongolia, Japan and China Mainland and Taiwan province. Methods The data on the incidence and mortality of HIV in post-neonatal population from East Asia were obtained from the Global Burden of Diseases (GBD). The morbidity and mortality of post-neonatal HIV population from GBD 2000 to GBD 2013 were applied as the training set and the morbidity and mortality from GBD 2014 to GBD 2019 were used as the testing set. The hybrid of ARIMA and LSTM model was used to construct the model for assessing the morbidity and mortality in the countries and territories of East Asia, and predicting the morbidity and mortality in the next 5 years. Results In North Korea, the incidence and mortality of HIV showed a rapid increase during 2000–2010 and a gradual decrease during 2010–2019. The incidence of HIV was predicted to be increased and the mortality was decreased. In South Korea, the incidence was increased during 2000–2010 and decreased during 2010–2019, while the mortality showed fluctuant trend. As predicted, the incidence of HIV in South Korea might be increased and the mortality might be decreased during 2020–2025. In Mongolia, the incidence and mortality were slowly decreased during 2000–2005, increased during 2005–2015, and rapidly decreased till 2019. The predicted incidence and mortality of HIV showed a decreased trend. As for Japan, the incidence of HIV was rapidly increased till 2010 and then decreased till 2015. The predicted incidence of HIV in Japan was gradually increased. The mortality of HIV in Japan was fluctuant during 2000–2019 and was slowly decreased as predicted. The incidence and mortality of HIV in Taiwan during 2000–2019 was increased on the whole. The predicted incidence of HIV during was stationary and the mortality was decreased. In terms of China Mainland, the incidence and mortality of HIV was fluctuant during 2000–2019. The predicted incidence of HIV in China Mainland was stationary while the mortality was rapidly decreased. Conclusion On the whole, the incidence of HIV combined with other diseases in post-neonatal population was increased before 2010 and then decreased during 2010–2019 while the mortality of those patients was decreased in East Asia.

show abstract

Global burden of disease study at the world health organization: research methods for the most comprehensive global study of disease and underlying health policies

Cited by 22 publications

References 18 publications

Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019

Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019

Global, regional and national burden of alopecia areata and its associated diseases, 1990–2019: A systematic analysis of the Global Burden of Disease Study 2019

A hybrid of long short-term memory neural network and autoregressive integrated moving average model in forecasting HIV incidence and morality of post-neonatal population in East Asia: global burden of diseases 2000–2019

Contact Info

Product

Resources

About